Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.

Metal complexing agents as therapies for Alzheimer’s disease

Bush, Ashley I·2002·Neurobiology of Aging

Abstract

Modern research approaches into drug development for Alzheimer's disease (AD) target beta-amyloid (Abeta) accumulation in the brain. The main approaches attempt to prevent Abeta production (secretase inhibitors) or to clear Abeta (vaccine). However, there is now compelling evidence that Abeta does not spontaneously aggregate, but that there is an age-dependent reaction with excess brain metal (copper, iron and zinc), which induces the protein to precipitate into metal-enriched masses (plaques). The abnormal combination of Abeta with Cu or Fe induces the production of hydrogen peroxide, which may mediate the conspicuous oxidative damage to the brain in AD. We have developed metal-binding compounds that inhibit the in vitro generation of hydrogen peroxide by Abeta, as well as reverse the aggregation of the peptide in vitro and from human brain post-mortem specimens. Most recently, one of the compounds, clioquinol (CQ; a USP antibiotic) was given orally for 9 weeks to amyloid-bearing transgenic mice, and succeeded in markedly inhibiting Abeta accumulation. On the basis of these results, CQ is being tested in clinical trials.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0197-4580(02)00120-3

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 81 references

Research works printed but not linked: 1

  1. Bush, 1999, The possible origin of free radicals from amyloid β peptides in Alzheimer’s disease, Neurobiol. Aging, 20, 335

Cited by

See all 311

Metadata

Authors
Bush, A. I.
Affiliations
Mental Health Research Institute (AU)
Corresponding author
Bush, Ashley I
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2002-11
Volume
23
Issue
6
Pages
1031-1038
ISSN
0197-4580 (ISSN-L)
OpenAlex
W1970159001
Cited by
310
References
81
Citations by year
2026: 2 · 2025: 3 · 2024: 7 · 2023: 8 · 2022: 4 · 2021: 8 · 2020: 8 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 9 · 2015: 10 · 2014: 15 · 2013: 15 · 2012: 20
FWCI
10.39
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
Alzheimer's disease, amyloid-beta, metal complexing agents, clioquinol, copper, iron, zinc, hydrogen peroxide, oxidative stress, amyloid fibril formation, secretase inhibitors, transgenic mice, drug development
MeSH terms
Alzheimer Disease, Amyloidosis, Animals, Brain, Chelating Agents, Copper, Humans, Hydrogen Peroxide, Clioquinol, Metals, Zinc, Amyloid beta-Peptides, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metal complexing agents as therapies for Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/s0197-4580(02)00120-3
The paper
Bush, A. I. (2002). Metal complexing agents as therapies for Alzheimer’s disease. Neurobiology of Aging. https://doi.org/10.1016/s0197-4580(02)00120-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.